NASDAQ:BBI
Delisted
Brickell Biotech Inc. Stock News
$1.94
+0 (+0%)
At Close: Feb 07, 2023
Accolade Shares Jump Around 29%, Here's 75 Biggest Movers From Friday
08:35am, Tuesday, 05'th Jul 2022 Benzinga
Gainers
Omeros Corporation (NASDAQ: OMER) jumped 68.7% to close at $4.64.
Clovis Oncology, Inc. (NASDAQ: CLVS) gained 58.3% to settle at $2.85 on Friday.
Fast Radius, Inc. (NASDAQ: FSRD) jumped 41.2
Brickell Biotech Announces 1-For-45 Reverse Stock Split
06:02pm, Friday, 01'st Jul 2022 GlobeNewswire Inc.
Common stock will begin trading on a split-adjusted basis on July 5, 2022 Common stock will begin trading on a split-adjusted basis on July 5, 2022
Brickell Biotech (BBI) Stock: 1-For-45 Reverse Split Announced
03:44pm, Friday, 01'st Jul 2022
Brickell Biotech, Inc. (Nasdaq: BBI) announced a 1-for-45 reverse split. These are the details.
Akerna Shares Dip 53%, Here's 78 Biggest Movers From Yesterday
08:52am, Friday, 01'st Jul 2022 Benzinga
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) surged 77.4% to close at $1.11 on Thursday after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phas
Why Is NeuroSense Therapeutics Jumping By 45%? 64 Stocks Moving In Thursday's Mid-Day Session
04:03pm, Thursday, 30'th Jun 2022 Benzinga
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) jumped 171.3% to $1.70 after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phase 1b CLEAR clinical
Aspen Aerogels And 28 Stocks Moving Premarket
10:33am, Thursday, 30'th Jun 2022 Benzinga
Gainers
Revelation Biosciences, Inc. (NASDAQ: REVB) rose 149.3% to $1.56 in pre-market trading after jumping 27% on Wednesday. Revelation Biosciences recently announced completion of dosing for Phas
This Healthcare Stock Surges Around 115%, Here's 74 Biggest Movers From Yesterday
08:55am, Thursday, 30'th Jun 2022 Benzinga
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) shares surged 114.3% to close at $0.2550 on Wednesday after the company announced it has terminated its previously announced at-the-market offerin
Why Is Allena Pharmaceuticals Jumping By 207%? 45 Stocks Moving In Wednesday's Mid-Day Session
04:32pm, Wednesday, 29'th Jun 2022 Benzinga
Gainers
Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) jumped 207% to $0.3650 after the company announced it has terminated its previously announced at-the-market offering.
Brickell Biotech, Inc. (NASD
Brickell Biotech (BBI) Stock Gains 50% Ahead of Meeting to Prevent Delisting
03:02pm, Wednesday, 29'th Jun 2022
Delistings are commonplace in this bear market, however investors in Brickell Biotech and BBI stock are cheering some news today. The post Brickell Biotech (BBI) Stock Gains 50% Ahead of Meeting to Pr
3 Penny Stocks To Watch After GDP Report
02:03pm, Wednesday, 29'th Jun 2022 PennyStocks
Penny stocks to buy or avoid right now? You decide after seeing the latest updates from 3 companies.
The post 3 Penny Stocks To Watch After GDP Report appeared first on Penny Stocks to Buy, Picks, New
3 Penny Stocks To Watch After GDP Report
10:03am, Wednesday, 29'th Jun 2022
Penny stocks to buy or avoid right now? You decide after seeing the latest updates from 3 companies.
Top Penny Stocks To Buy? 4 Biotech Stocks To Watch Now
11:20pm, Thursday, 09'th Jun 2022 PennyStocks
Biotech penny stocks to watch in June.
The post Top Penny Stocks To Buy? 4 Biotech Stocks To Watch Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
Top Penny Stocks To Buy? 4 Biotech Stocks To Watch Now
07:20pm, Thursday, 09'th Jun 2022
Biotech penny stocks to watch in June. The post Top Penny Stocks To Buy?
Benzinga's Top Ratings Upgrades, Downgrades For May 13, 2022
02:01pm, Friday, 13'th May 2022 Benzinga
Upgrades
B of A Securities upgraded the previous rating for Ritchie Bros Auctioneers Inc (NYSE:RBA) from Underperform to Neutral. In the first quarter, Ritchie Bros Auctioneers showed an EPS of $0.46,
Brickell (BBI) Reports Q1 Loss, Lags Revenue Estimates
09:35pm, Thursday, 12'th May 2022 Zacks Investment Research
Brickell (BBI) delivered earnings and revenue surprises of -33.33% and 52.33%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?